Position in GSK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$607,233
+$20,564 QoQ
Shares Held
11,584
+9.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#440
of 1,030 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beutel, Goodman & Co Ltd. holds $470,436,702 across 7 Drug Manufacturers - General names. GSK ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
2,073,206 | $266,406,971 | |
| 2 | AMGN |
Amgen Inc
|
520,577 | $188,511,343 | |
| 3 | JNJ |
Johnson & Johnson
|
36,671 | $9,313,333 | |
| 4 | NVS |
Novartis AG
|
18,599 | $2,914,835 | |
| 5 | NVO |
Novo Nordisk A S
|
55,413 | $2,656,499 | |
| 6 | GSK |
GSK plc
This page
|
11,584 | $607,233 | |
| 7 | PFE |
Pfizer Inc
|
1,100 | $26,488 |
All Filings in GSK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $607,233 | 11,584 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $586,669 | 10,630 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $702,252 | 14,320 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $763,500 | 17,690 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $670,080 | 17,450 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $495,097 | 12,780 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $429,514 | 12,700 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $543,295 | 13,290 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $506,660 | 13,160 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $564,169 | 13,160 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $483,633 | 13,050 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $305,587 | 8,430 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $299,732 | 8,410 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $254,397 | 7,150 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $218,922 | 6,230 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $274,581 | 9,330 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $545,418 | 12,775 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $564,165 | 13,205 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $529,203 | 12,235 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $420,859 | 11,230 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $438,592 | 11,230 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $354,598 | 10,130 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $43,673 | 1,210 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $30,641 | 830 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||